NCT00082043View on ClinicalTrials.gov

Dutasteride to Treat Women With Menstrually Related Mood Disorders

PHASE1CompletedINTERVENTIONAL
Enrollment

34

Participants

Timeline

Start Date

March 31, 2004

Primary Completion Date

March 6, 2014

Study Completion Date

March 6, 2014

Conditions
Premenstrual SyndromePMSHealthyDepression
Interventions
DRUG

Dutasteride

DRUG

Placebo oral capsule

Trial Locations (1)

20892

National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda

All Listed Sponsors
lead

National Institute of Mental Health (NIMH)

NIH

NCT00082043 - Dutasteride to Treat Women With Menstrually Related Mood Disorders | Biotech Hunter | Biotech Hunter